SCHEMBL8354928

SCHEMBL8354928

COC(=O)c1cc(S(C)(=O)=O)cc(I)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
TSHR P16473 2/20 0.42
LMNA P02545 2/20 0.41
ABL1 P00519 1/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CFTR P13569 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
PTGS2 P35354 3/20 0.36
GAA P10253 2/20 0.36
CA2 P00918 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
EPAS1 Q99814 1/20 0.34
CA1 P00915 1/20 0.34
CA5A P35218 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8356473 0.83 MAPT (0.38) ALDH1A1TSHRLMNAKDM4EHSD17B10
SCHEMBL3215571 0.83 KDM4E (0.38) ALDH1A1TSHRLMNAKDM4EHSD17B10
SCHEMBL8354895 0.81 CA2 (0.41) ALDH1A1TSHRKDM4EHSD17B10SMN1; SMN2
SCHEMBL8355025 0.81 ALDH1A1 (0.42) ALDH1A1TSHRLMNAABL1KDM4E
SCHEMBL15390859 0.78 ABL1 (0.46) ALDH1A1LMNAABL1KDM4ESMN1; SMN2
SCHEMBL1809801 0.78 LMNA (0.46) ALDH1A1TSHRLMNAKDM4EHSD17B10
SCHEMBL1017860 0.78 KDM4E (0.45) ALDH1A1TSHRLMNAKDM4EHSD17B10
SCHEMBL2511792 0.75 GAA (0.45) ALDH1A1TSHRLMNAABL1KDM4E
SCHEMBL27630669 0.75 ALDH1A1 (0.47) ALDH1A1TSHRLMNAABL1KDM4E
SCHEMBL8358401 0.75 ALDH1A1 (0.42) ALDH1A1TSHRLMNAKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6001881-A Ortho-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament comprising them HOECHST AKTIENGESELLSCHAFT (DE) 1999-12-14 US disclosed